Oncology CME

Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
11 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
Roy Decker, MD, PhD
7 December, 2018
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Amir Fathi, MD
5 December, 2018
Credits: 1.00 MOC / CME
Medical Learning Institute, Inc.
Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing: Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution
Kurt Schalper, MD, PhD / Edward B. Garon, MD, MS
30 November, 2018
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Anjali Saqi, MD, MBA / Geoffrey R. Oxnard, MD
29 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department
Daniel Pallin, MD, MPH
21 November, 2018
Credits: 1.00 MOC / CME / CE
Medical Learning Institute, Inc.
Treatment Innovation in Hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Mark Reding, MD
6 November, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Integrating BTK Inhibitors Into the Management of B-Cell Malignancies: How Is Evidence Driving Patient Care?
Michael Wang, MD
12 October, 2018
Credits: 1.00 CME
Penn State College of Medicine
Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for Delivering Evidence-Based, Patient-Centered Care
Neal Shore, MD, FACS
11 October, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
Nathan Fowler, MD
9 October, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care
Omid Hamid, MD
11 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors
George Demetri, MD
9 July, 2018
Credits: 2.00 CME
Penn State College of Medicine
The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
John Leonard, MD
5 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
Edward Garon, MD, MS
5 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management
Johanna Bendell, MD
5 July, 2018
Credits: 1.50 CME
Penn State College of Medicine
Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care
Robert Dreicer, MD, MS, MACP, FASCO
5 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care
Farhad Ravandi, MD
3 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors
Prof Eric Van Cutsem, MD, PhD
3 July, 2018
Credits: 1.50 CME
Penn State College of Medicine
A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
Robert Orlowski, MD, PhD
3 July, 2018

Pages